IMPROVING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

during the speedily evolving area of oncology research, correct and economical mutation screening is essential for acquiring qualified therapies. The KRAS solutions System plays a pivotal position Within this landscape by presenting extensive answers for KRAS mutation profiling and Investigation. KRAS mutations, present in approximately 95% of RAS-